Europe Ultrasound Gels Market – Industry Trends and Forecast to 2029

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Europe Ultrasound Gels Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Oct 2022
  • Europe
  • 350 Páginas
  • Número de tablas: 154
  • Número de figuras: 35

Europe Ultrasound Gels Market, By Type (Sterile And Non-Sterile), Application (Abdominal Ultrasound, Obstetric Ultrasound, Hysterosonography, Pelvic Ultrasound, Musculoskeletal Ultrasound, Breast Ultrasound, Prostate Ultrasound, Carotid Ultrasound, Venous Ultrasound (Extremities), Scrotal Ultrasound, Thyroid Ultrasound And Others), End User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers and Others), Distribution Channel (Retail Sales, Online Sales and Direct Tender) - Industry Trends and Forecast to 2029.

Europe Ultrasound Gels Market

Europe Ultrasound Gels Market Analysis and Insights

Ultrasound gels are one of the widely used gels used for various ultrasound procedures involving Hysterosonography, Obstetric Ultrasound, Abdominal Ultrasound, Breast Ultrasound, Carotid Ultrasound, Musculoskeletal Ultrasound, Pelvic Ultrasound, Prostate Ultrasound, Scrotal Ultrasound, Thyroid Ultrasound, Venous Ultrasound among others. Ultrasound gels is an anti- TNF drug indicated for the treatment of inflammatory symptoms. Medical professionals use biologic ultrasound gels for clear and precise diagnostics.

Europe Ultrasound Gels Market

Europe Ultrasound Gels Market

Europe ultrasound gels market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2022 to 2029 and is expected to reach USD 39,078.25 thousand by 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customisable 2019-2014)

Quantitative Units

Revenue in USD Thousand

Segments Covered

By Type (Sterile And Non-Sterile), Application (Abdominal Ultrasound, Obstetric Ultrasound, Hysterosonography, Pelvic Ultrasound, Musculoskeletal Ultrasound, Breast Ultrasound, Prostate Ultrasound, Carotid Ultrasound, Venous Ultrasound (Extremities), Scrotal Ultrasound, Thyroid Ultrasound And Others), End User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers and Others), Distribution Channel (Retail Sales, Online Sales and Direct Tender)

Countries Covered

Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Belgium, Turkey and the Rest of Europe

Market Players Covered

The major companies operating in the market are Medline Industries LP, Deas s.r.l, HR Pharmaceuticals Inc, FIAB SpA, Gima S.p.A, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa(Subsidiary of AB Medica Group), Rays S.P.A among others

 Market Definition:

Ultrasound gels are one of the most commonly used gels during ultrasound procedures. Ultrasound gels are used to get clear and precise imaging during diagnostics. These are the type of conductive medium applied to the skin and act as a coupling agent and therefore help form a tight bond between the skin and the probe. This gel also helps ultrasound waves to convey straight to the tissues and other parts where imaging is required.

Ultrasound Gels Market Dynamics

Drivers

  • Rising Ultrasound Procedures

High-frequency sound waves perform an ultrasound scan to image a person's internal body structures. Doctors or clinicians apply ultrasound gels on a patient's body parts for deep, precise and clear medical imaging. As growing technology enables high-resolution images in medical ultrasound, it is becoming easier to diagnose the internal body correctly. Due to its cost-effective nature and increased awareness regarding periodical check-ups for healthier bodies, the number of ultrasound scans is rising. Ultrasounds gels are the most convenient and reliable product during these scans. The dependency of clinicians and doctors on ultrasounds has increased regularly. These procedures are commonly used to examine the liver, kidneys and other organs in the stomach, pelvis and other organs or tissues that can be assessed through the skin. Rise in geriatric population

  • Easy Usage and Patient-Friendly Diagnosis

When scanning, ultrasound gels are most often used by clinicians, doctors and medical staff as these gels help prevent air between the ultrasonic waves from the scanner to the gel-applied body part. Most ultrasound procedures are painless as they are non-invasive and are done externally, only the gels are applied to the body and the transducer is placed nearby contact with the skin as it passes light waves, which gives negligible effect on the person's body. Ultrasound procedures use high-frequency sound waves to create an image of part of the inside of the body, as ultrasound gels best capture these images. These gels applied on the skin are easy to use and do not cause any body pain. Therefore, the easy and painless ultrasound procedure will aid in the growth of the market in the forecast period

Europe Ultrasound Gels Market

Opportunities

  • The Rise In Healthcare Expenditure

Healthcare expenditure has increased worldwide as people's disposable income in various countries increases. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure. Also, the rise in healthcare expenditure by the government in the region will provide structural integrity and future opportunities for the ultrasound gels market in the forecast period of 2022-2029.

Restraints/Challenges

There are various and several skin problems and allergies are reported due to the usage of ultrasound gels. Some develop these problems because of their sensitive skin. Contact dermatitis has occurred in a small population of patients due to ultrasound gels use. Other Bacterial contamination may also develop sometimes on the patient's skin where the gels are being applied. Some formulations or different compositions of gels heat up when treated under UV light due to exothermic reaction. The thicker the gels could be, the more heat is produced. Hence, the side effects associated with using ultrasound gels may hamper the market growth in the forecast period.

Post-COVID-19 Impact on Europe Ultrasound Gels market

COVID-19 has affected the growth of the market as there is a rise in the ultrasound procedures in the region, such as hysterosonography, obstetric ultrasound, abdominal ultrasound, breast ultrasound, carotid ultrasound, musculoskeletal ultrasound, pelvic ultrasound, prostate ultrasound, scrotal ultrasound, thyroid ultrasound, venous ultrasound, others. Hence, the need for the ultrasound gels keeps rising during the COVID period.

Recent Development

  • In April 2019, Civco Medical Solutions launched a new solution—Envision Viral Barrier—that eliminates the use of gels in ultrasound procedures. This product consists of an ultrasound probe cover and a scanning pad with a sterile liquid that facilitates 100% gel-free procedures. Such technological advancements help reduce the risk of contamination and ease clinician workflows in healthcare settings, which may impede the market growth

Europe Ultrasound Gels Market Scope

Europe ultrasound gels market is segmented into type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Application

  • Abdominal Ultrasound
  • Obstetric Ultrasound
  • Hysterosonography
  • Pelvic Ultrasound
  • Musculoskeletal Ultrasound
  • Breast Ultrasound
  • Prostate Ultrasound
  • Carotid Ultrasound
  • Venous Ultrasound (Extremities)
  • Scrotal Ultrasound
  • Thyroid Ultrasound
  • Others

On the basis of application, the Europe ultrasound gels market is segmented into abdominal ultrasound, obstetric ultrasound, hysterosonography, pelvic ultrasound, musculoskeletal ultrasound, breast ultrasound, prostate ultrasound, carotid ultrasound, venous ultrasound (extremities), scrotal ultrasound, thyroid ultrasound and others.

Type

  • Sterile Ultrasound Gels
  • Non-Sterile Ultrasound Gels

On the basis of type, the Europe ultrasound gels market is segmented into sterile and non-sterile ultrasound gels.

End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others

On the basis of end-users, the Europe ultrasound gels market is segmented into hospitals, clinics, diagnostic centers, ambulatory surgical centers and others.

Distribution Channel

  • Retail Sales
  • Online Sales
  • Direct Tender

Europe Ultrasound Gels Market

On the basis of distribution channel, the Europe ultrasound gels market is segmented into retail sales, online sales and direct tender.

Market Definition

Ultrasound gels is one of the commonly used gels and is majorly used during ultrasound procedures. Ultrasound gels are used to get clear and precise imaging during diagnostics these are the type of conductive medium which is applied to the skin and acts as a coupling agent and therefore helps in forming tight bond between the skin and the probe. This gel also helps ultrasound waves to convey straight to the tissues and other parts where imaging is required.

Europe Ultrasound Gels Market Regional Analysis/Insights     

The ultrasound gels market is analyzed and market size insights and trends are provided by country, type, application, end-user and distribution channel, as referenced above.

Countries comprises in the Europe ultrasound gels market are Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Belgium, Turkey and the Rest of Europe.

Germany dominates the ultrasound gels market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rise in the prevalence of various chronic diseases and research and development in drug development in Germany further improve this market growth.

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing a forecast analysis of the country data.

Competitive Landscape and Market Share Analysis

The ultrasound gels market competitive landscape provides details about the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth and application dominance. The above data points are only related to the companies focus on the Europe ultrasound gels market.

Some of the major players operating in the Europe ultrasound gels market are Medline Industries LP, Deas s.r.l, HR Pharmaceuticals Inc, FIAB SpA, Gima S.p.A, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa (Subsidiary of AB Medica Group), Rays S.P.A, among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Europe vs. Regional and Vendor Share Analysis. Please request an analyst call in case of further inquiry.


SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE ULTRASOUND GELS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END-USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

4.3 NUMBER OF ULTRASOUND PROCEDURES, BY COUNTRY

4.3.1 NUMBER OF ABDOMINAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.2 NUMBER OF OBSTETRIC ULTRASOUND PROCEDURES, BY COUNTRY

4.3.3 NUMBER OF HYSTEROSONOGRAPHY ULTRASOUND PROCEDURES, BY COUNTRY

4.3.4 NUMBER OF BREAST ULTRASOUND PROCEDURES, BY COUNTRY

4.3.5 NUMBER OF CAROTID ULTRASOUND PROCEDURES, BY COUNTRY

4.3.6 NUMBER OF MUSCULOSKELETAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.7 NUMBER OF PELVIC ULTRASOUND PROCEDURES, BY COUNTRY

4.3.8 NUMBER OF PROSTATE ULTRASOUND PROCEDURES, BY COUNTRY

4.3.9 NUMBER OF SCROTAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.10 NUMBER OF THYROID ULTRASOUND PROCEDURES, BY COUNTRY

4.3.11 NUMBER OF VENOUS (EXTREMITIES) ULTRASOUND PROCEDURES, BY COUNTRY

5 EUROPE ULTRASOUND GELS MARKET: REGULATIONS

5.1 REGULATION IN EUROPE

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING ULTRASOUND PROCEDURES

6.1.2 EASY USAGE AND PATIENT-FRIENDLY PAINLESS DIAGNOSIS

6.1.3 VERSATILE IN NATURE, HAVE VARIOUS DIFFERENT FORMULATIONS

6.2 RESTRAINTS

6.2.1 UNPLEASANT SIDE EFFECTS SUCH AS ALLERGIES OR SKIN PROBLEMS

6.2.2 LOW-COST SUBSTITUTES

6.3 OPPORTUNITIES

6.3.1 RISE IN HEALTHCARE EXPENDITURE

6.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

6.3.3 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

6.4 CHALLENGES

6.4.1 UPCOMING TECHNOLOGICAL ADVANCEMENTS ELIMINATING THE USE OF ULTRASOUND GEL

6.4.2 RISK ASSOCIATED WITH USE OF NON-STERILE ULTRASOUND GEL IN GERIATRIC PATIENTS

7 EUROPE ULTRASOUND GELS MARKET, BY TYPE

7.1 OVERVIEW

7.2 NON-STERILE ULTRASOUND GELS

7.3 STERILE ULTRASOUND GELS

8 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 ABDOMINAL ULTRASOUND

8.2.1 NON-STERILE ULTRASOUND GELS

8.2.2 STERILE ULTRASOUND GELS

8.3 OBSTETRIC ULTRASOUND

8.3.1 NON-STERILE ULTRASOUND GELS

8.3.2 STERILE ULTRASOUND GELS

8.4 HYSTEROSONOGRAPHY

8.4.1 NON-STERILE ULTRASOUND GELS

8.4.2 STERILE ULTRASOUND GELS

8.5 PELVIC ULTRASOUND

8.5.1 NON-STERILE ULTRASOUND GELS

8.5.2 STERILE ULTRASOUND GELS

8.6 MUSCULOSKELETAL ULTRASOUND

8.6.1 NON-STERILE ULTRASOUND GELS

8.6.2 STERILE ULTRASOUND GELS

8.7 BREAST ULTRASOUND

8.7.1 NON-STERILE ULTRASOUND GELS

8.7.2 STERILE ULTRASOUND GELS

8.8 PROSTATE ULTRASOUND

8.8.1 NON-STERILE ULTRASOUND GELS

8.8.2 STERILE ULTRASOUND GELS

8.9 CAROTID ULTRASOUND

8.9.1 NON-STERILE ULTRASOUND GELS

8.9.2 STERILE ULTRASOUND GELS

8.1 VENOUS ULTRASOUND (EXTERMITIS)

8.10.1 NON-STERILE ULTRASOUND GELS

8.10.2 STERILE ULTRASOUND GELS

8.11 SCROTAL ULTRASOUND

8.11.1 NON-STERILE ULTRASOUND GELS

8.11.2 STERILE ULTRASOUND GELS

8.12 THYROID ULTRASOUND

8.12.1 NON-STERILE ULTRASOUND GELS

8.12.2 STERILE ULTRASOUND GELS

8.13 OTHERS

9 EUROPE ULTRASOUND GELS MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 DIAGNOSTIC CENTERS

9.4 CLINICS

9.5 AMBULATORY SURGICAL CENTERS

9.6 OTHERS

10 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 RETAIL SALES

10.3 ONLINE SALES

10.4 DIRECT TENDER

11 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY

11.1 GERMANY

11.2 FRANCE

11.3 U.K.

11.4 ITALY

11.5 TURKEY

11.6 SPAIN

11.7 NETHERLANDS

11.8 BELGIUM

11.9 SWITZERLAND

11.1 REST OF EUROPE

12 EUROPE ULTRASOUND GELS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 PARKER LABORATORIES, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 PRODUCT PORTFOLIO

14.1.3 RECENT DEVELOPMENTS

14.2 OPTIMUM MEDICAL LIMITED

14.2.1 COMPANY SNAPSHOT

14.2.2 PRODUCT PORTFOLIO

14.2.3 RECENT DEVELOPMENTS

14.3 FIAB SPA

14.3.1 COMPANY SNAPSHOT

14.3.2 PRODUCT PORTFOLIO

14.3.3 RECENT DEVELOPMENTS

14.4 DEAS S.R.L.

14.4.1 COMPANY SNAPSHOT

14.4.2 PRODUCT PORTFOLIO

14.4.3 RECENT DEVELOPMENTS

14.5 HR PHARMACEUTICALS, INC.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENTS

14.6 BRAUN & CO. LIMITED

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 DJO, LLC

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 FANNIN

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 GIMA S.P.A.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 LESSA (SUBSIDIARY OF AB MEDICA GROUP)

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 MEDLINE INDUSTRIES, LP.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 PRIMAX BERLIN GMBH

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 PROSYS INTERNATIONAL LTD

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 RAYS S.P.A

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 SAFERSONIC

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 TURQUOISE HEALTH

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

Lista de Tablas

TABLE 1 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 2 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (VOLUME, IN THOUSAND)

TABLE 3 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 4 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 5 EUROPE ABDOMINAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 6 EUROPE OBSTETRIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 7 EUROPE HYSTEROSONOGRAPHY IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 8 EUROPE PELVIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 9 EUROPE MUSCULOSKELETAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 10 EUROPE BREAST ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 11 EUROPE PROSTATE ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 12 EUROPE CAROTID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 13 EUROPE VENOUS ULTRASOUND (EXTREMITIS) IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 14 EUROPE SCROTAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 15 EUROPE THYROID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 16 EUROPE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 17 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 18 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 19 GERMANY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 20 GERMANY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 21 GERMANY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 22 GERMANY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 23 GERMANY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 24 GERMANY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 25 GERMANY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 26 ERMANY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 27 GERMANY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 28 GERMANY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 29 GERMANY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 30 GERMANY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 31 GERMANY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 32 GERMANY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 33 GERMANY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 34 FRANCE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 35 FRANCE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 36 FRANCE ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 37 FRANCE OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 38 FRANCE HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 39 FRANCE PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 40 FRANCE MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 41 FRANCE BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 42 FRANCE PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 43 FRANCE CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 44 FRANCE VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 45 FRANCE SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 46 FRANCE THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 47 FRANCE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 48 FRANCE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 49 U.K. ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 50 U.K. ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 51 U.K. ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 52 U.K. OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 53 U.K. HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 54 U.K. PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 55 U.K. MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 56 U.K. BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 57 U.K. PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 58 U.K. CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 59 U.K. VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 60 U.K. SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 61 U.K. THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 62 U.K. ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 63 U.K. ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 64 ITALY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 65 ITALY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 66 ITALY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 67 ITALY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 68 ITALY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 69 ITALY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 70 ITALY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 71 ITALY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 72 ITALY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 73 ITALY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 74 ITALY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 75 ITALY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 76 ITALY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 77 ITALY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 78 ITALY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 79 TURKEY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 80 TURKEY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 81 TURKEY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 82 TURKEY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 83 TURKEY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 84 TURKEY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 85 TURKEY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 86 TURKEY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 87 TURKEY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 88 TURKEY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 89 TURKEY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 90 TURKEY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 91 TURKEY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 92 TURKEY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 93 TURKEY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 94 SPAIN ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 95 SPAIN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 96 SPAIN ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 97 SPAIN OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 98 SPAIN HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 99 SPAIN PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 100 SPAIN MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 101 SPAIN BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 102 SPAIN PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 103 SPAIN CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 104 SPAIN VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 105 SPAIN SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 106 SPAIN THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 107 SPAIN ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 108 SPAIN ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 109 NETHERLANDS ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 110 NETHERLANDS ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 111 NETHERLANDS ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 112 NETHERLANDS OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 113 NETHERLANDS HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 114 NETHERLANDS PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 115 NETHERLANDS MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 116 NETHERLANDS BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 117 NETHERLANDS PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 118 NETHERLANDS CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 119 NETHERLANDS VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 120 NETHERLANDS SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 121 NETHERLANDS THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 122 NETHERLANDS ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 123 NETHERLANDS ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 124 BELGIUM ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 125 BELGIUM ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 126 BELGIUM ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 127 BELGIUM OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 128 BELGIUM HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 129 BELGIUM PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 130 BELGIUM MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 131 BELGIUM BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 132 BELGIUM PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 133 BELGIUM CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 134 BELGIUM VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 135 BELGIUM SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 136 BELGIUM THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 137 BELGIUM ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 138 BELGIUM ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 139 SWITZERLAND ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 140 SWITZERLAND ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 141 SWITZERLAND ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 142 SWITZERLAND OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 143 SWITZERLAND HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 144 SWITZERLAND PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 145 SWITZERLAND MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 146 SWITZERLAND BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 147 SWITZERLAND PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 148 SWITZERLAND CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 149 SWITZERLAND VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 150 SWITZERLAND SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 151 SWITZERLAND THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 152 SWITZERLAND ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 153 SWITZERLAND ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 154 REST OF EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

Lista de figuras

FIGURE 1 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION

FIGURE 2 EUROPE ULTRASOUND GELS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE ULTRASOUND GELS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE ULTRASOUND GELS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE ULTRASOUND GELS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE ULTRASOUND GELS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE ULTRASOUND GELS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE ULTRASOUND GELS MARKET: MARKET END-USER COVERAGE GRID

FIGURE 9 EUROPE ULTRASOUND GELS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION

FIGURE 11 THE INCREASING PREVALENCE OF ULTRASOUND PROCEDURES AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE ULTRASOUND GELS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 THE NON-STERILE ULTRASOUND GELS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ULTRASOUND GELS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL MRI COILS MARKET

FIGURE 14 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2021

FIGURE 15 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2022-2029 (USD THOUSAND)

FIGURE 16 EUROPE ULTRASOUND GELS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 17 EUROPE ULTRASOUND GELS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2021

FIGURE 19 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2022-2029 (USD THOUSAND)

FIGURE 20 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 21 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 22 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2021

FIGURE 23 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2022-2029 (USD THOUSAND)

FIGURE 24 EUROPE ULTRASOUND GELS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 25 EUROPE ULTRASOUND GELS MARKET: BY END USER, LIFELINE CURVE

FIGURE 26 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 27 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD THOUSAND)

FIGURE 28 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 29 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 30 EUROPE ULTRASOUND GELS MARKET: SNAPSHOT (2021)

FIGURE 31 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021)

FIGURE 32 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 EUROPE ULTRASOUND GELS MARKET: BY TYPE (2022 & 2029)

FIGURE 35 EUROPE ULTRASOUND GELS MARKET: COMPANY SHARE 2021 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The Europe Ultrasound Gels Market is projected to grow at a CAGR of 6.1% during the forecast period by 2029.
The future market value of the Europe Ultrasound Gels Market is expected to reach USD 39,078.25 thousand by 2029.
The major players in the Europe Ultrasound Gels Market Medline Industries LP, Deas s.r.l, HR Pharmaceuticals Inc, FIAB SpA, Gima S.p.A, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa(Subsidiary of AB Medica Group), Rays S.P.A among others.
The country covered in the Europe Ultrasound Gels Market are Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Belgium, Turkey and the Rest of Europe.